The short version
Sex and intimacy do not switch off at 60, 70 or 80, but they often change shape. Bodies change, medicines and illnesses get involved, partners die or become unwell, and the old script (arousal, intercourse, finish) stops working reliably. For most people that is a problem with real, practical answers, not a verdict on whether intimacy is over.
This guide is for readers in their 50s to 80s, partnered or alone. Where a claim is load-bearing it carries an evidence label: STRONG, MODERATE, EMERGING, CONTESTED or UNEVIDENCED. It is educational information, not individual medical advice.
What older adults actually report
The best-known population data come from Lindau and colleagues (2007), who surveyed a national probability sample of 3,005 US adults aged 57 to 85. Reported sexual activity fell with age: 73 per cent of those aged 57 to 64, 53 per cent of those aged 65 to 74 and 26 per cent of those aged 75 to 85. Among people who were sexually active, about half of both men and women reported at least one bothersome sexual problem. It is a US survey, so treat the figures as a snapshot, not an Australian count.
The most common problems among women in that sample were low desire (43 per cent), difficulty with vaginal lubrication (39 per cent) and inability to climax (34 per cent); among men the most common was erectile difficulty (37 per cent). Poor self-rated health went with being less sexually active and, among the active, with more problems. Only 38 per cent of men and 22 per cent of women had discussed sex with a doctor since turning 50. If you have never raised it, you are in the majority, but it is worth doing.
Menopause, dryness and pain
Genitourinary syndrome of menopause (GSM) is the umbrella term for the vaginal, vulval and urinary changes that follow falling oestrogen: dryness, burning, irritation, pain with penetration and urinary symptoms. The North American Menopause Society's 2020 position statement says GSM affects approximately 27 to 84 per cent of postmenopausal women (a wide range that reflects how it is measured), that it can significantly impair sexual function and quality of life, and that it is likely underdiagnosed and undertreated. Crucially, it says that in most cases symptoms can be effectively managed.
The options it lists include vaginal lubricants and moisturisers, vaginal oestrogen, vaginal DHEA, systemic hormone therapy and ospemifene (a prescription medicine). It also notes that long-term endometrial safety data for some of these are lacking and that there are too few placebo-controlled trials of energy-based treatments such as lasers to recommend them. Evidence label: STRONG that GSM is common and treatable; the choice between products is an individual medical decision, especially after breast cancer or with other hormone-sensitive conditions.
Lubricants are used during sex; moisturisers are used regularly, not only before sex. A review by Edwards and Panay (2015) concludes that both can relieve discomfort and pain during intercourse in mild to moderate dryness, particularly for women who cannot or choose not to use oestrogen, and that products differ in osmolality and pH. It is a narrative review, not a trial, so the label is MODERATE. Pain that continues despite these measures deserves a proper assessment; see our guide to dyspareunia treatment options.
Erections, desire and the heart
Erectile difficulty becomes more common with age, but it is also a health signal. The 2024 Princeton IV consensus conference, a multispecialty expert panel, states that mounting evidence supports treating men with erectile dysfunction as being at risk for cardiac events until proven otherwise. That is why a doctor will usually check blood pressure, blood sugar, cholesterol and heart health, not just write a script. This is an expert consensus, so the label is MODERATE, but it is consistent across the field and it is the reason this guide sends you to a GP first.
Medicines that work are a legitimate part of the answer. A 2021 network meta-analysis (Madeira and colleagues) covering 179 randomised trials and 50,620 men found that all PDE5 inhibitors (the sildenafil and tadalafil family) were significantly more effective than placebo for erectile function, with different side-effect profiles between drugs. Evidence label: STRONG that PDE5 inhibitors work for erectile dysfunction in general; which drug and dose suits you, and whether it is safe alongside your heart condition and other medicines, is a prescriber decision.
Desire is different. It is not a single switch, and it responds to health, mood, relationship quality, pain and medication as much as to hormones. Low desire is common in the Lindau data and is treated as a legitimate concern, not a fault. For men whose erections are unreliable, our guide to unreliable erections and learning to receive covers the non-medical side: taking the pressure off the erection and widening what counts as intimacy.
Medications, chronic illness and surgery
Many ordinary medicines affect sexual function. The clearest evidence is for antidepressants: a 2009 meta-analysis by Serretti and Chiesa found significantly higher rates of treatment-emergent sexual dysfunction than placebo for several common antidepressants, ranging from 25.8 to 80.3 per cent of patients depending on the drug, and no significant difference from placebo for agomelatine, bupropion, mirtazapine, moclobemide, amineptine and nefazodone. The authors note that some assumptions (including open-label studies) may weaken the findings. Never stop or change a medicine on your own because of a page like this; ask the prescriber whether an alternative or adjustment exists.
Chronic illness, pain, fatigue, incontinence, joint problems and surgery (including prostate, pelvic or breast surgery) can all change how sex works, and poor self-rated health tracked with fewer sexually active people in the survey above. We have not cited a source covering every condition, so the honest advice is to tell your treating doctor that sex matters to you and ask what your condition or procedure usually does to it. Our guides on recovery after prostate surgery and sex after cancer cover specifics.
Pelvic-floor physiotherapy
Pelvic-floor physiotherapy is worth knowing about because it addresses pain, tension and weakness, which can all affect sex. A 2019 single-arm feasibility study (Mercier and colleagues) enrolled 32 postmenopausal women with GSM in a 12-week pelvic-floor muscle training programme. Completion and participation were high (91 per cent completed), and symptoms, signs and sexual function improved afterwards. With no comparison group, it cannot show the programme caused the improvement. Evidence label: EMERGING for GSM specifically.
A physiotherapist with pelvic-health training can assess whether muscles are too tight or too weak, and the answer changes the exercise. Ask your GP for a referral.
Sensate focus, mindfulness and communication
Sensate focus is a structured touch exercise from Masters and Johnson's sex therapy in which partners take turns touching and being touched without the goal of arousal or intercourse. A critical review by Linschoten, Weiner and Avery-Clark (2016) says that research on its efficacy with populations beyond the original studies has been limited and calls for more. So we label it MODERATE as established clinical practice and EMERGING as proven in older adults specifically. Our sensate focus complete guide walks through the stages in plain language.
Mindfulness-based therapy has more trial data, mostly in women. A 2017 meta-analysis by Stephenson and Kerth pooled 11 trials with 449 participants and found improvements in sexual function with generally moderate effect sizes, with caveats about possible publication bias and small, varied studies. We found no trials of mindfulness-based therapy aimed at older adults specifically. Label: MODERATE for women with desire and arousal difficulties, EMERGING for men and for older adults.
Communication has no glamorous trial behind it, but it does a lot of work: say what you want, say what hurts, and agree that sex can end in cuddling.
Myths that need retiring
Myth: older people are not interested. The survey data show that many are active. Myth: if the erection or lubrication has changed, intimacy is over. Intercourse is one option among many.
Myth: desire should be spontaneous and constant. A widely taught clinical model holds that, for many people at any age, desire follows touch and context rather than preceding it, which is one reason structured touch exercises are used. We have not cited a trial for that model here. Myth: supplements and gadgets sold online are as good as medical care. We have not verified evidence that they are. Ask a pharmacist or GP before buying anything marketed for sexual function.
Loneliness, touch and being on your own
If you are widowed, divorced or single, sexual intimacy is only one part of a bigger need for touch and company. A 2015 meta-analysis by Holt-Lunstad and colleagues found that social isolation, loneliness and living alone were each associated with a higher likelihood of mortality (odds ratios of about 1.29, 1.26 and 1.32 respectively), comparable to better-known risk factors. That is an association from observational studies, not proof that touch or sex extends life, but it supports taking connection seriously.
Options include friendship and community groups, therapeutic touch from a qualified practitioner, pets and, when ready, new relationships. Self-touch is a legitimate way to stay in touch with your own body, and we found no source advising against it at any age. If grief is making everything flat, a GP or counsellor can help; grief is not a sexual dysfunction to be fixed by technique. Our guide to returning to intimacy after celibacy is useful if it has been a long time.
Caring for a partner, and consent in care settings
When one partner becomes the carer, the relationship can quietly shift from lovers to patient and nurse. That is common and often goes unspoken. Naming it and protecting time and touch that are not caregiving are sensible steps. We could not verify a trial for this, so treat it as practical guidance, not an evidence-graded claim.
For people living with dementia and in residential care, Dementia Australia states that a diagnosis does not automatically remove the capacity to consent, that capacity can change over time or even day to day, and that it is decision-specific: a person may be able to consent to intimacy but not to financial decisions. Where capacity is in doubt, it advises seeking a medical specialist's advice. Editorially, we would add that protecting people from harm and avoiding the assumption that every expression of intimacy is a problem both matter, and that residents' own wishes belong at the centre.
Where a tantric or somatic framing fits
Tantric and somatic practices can be a gentle, pleasure-positive way to practise the skills the evidence supports: slow breathing, attention to sensation, non-goal-oriented touch and honest communication. They share a mechanism with sensate focus and mindfulness. There are no direct, high-quality trials of tantric practice in older adults. Evidence label for tantra as a treatment: UNEVIDENCED; for the underlying skills as an adjunct: EMERGING.
So the sensible order is: medical check first, treatment of anything treatable (dryness, erections, pain, medicines), then a slower, more sensory way of being together if you want it. Breath and body-awareness practices are low-risk additions. They should not replace a doctor, hormone treatment, pelvic-floor care or sex therapy, and nobody should promise you an outcome. For breath-based practice, see our notes on tantric breathwork and on conscious sexuality.
Red flags and who to see
See a doctor promptly for any bleeding after menopause. Healthdirect Australia says always to see your doctor for it, because it can sometimes signal a serious condition, including cancers of the uterus, cervix, ovary or vagina, although it can also come from thinning of the vaginal lining, polyps, infection or hormone therapy. A new or worsening erectile problem, new pain with sex, pain that does not settle, urinary symptoms, sudden loss of desire alongside other changes, or a change that began with a new medicine also deserve a check. Chest pain or breathlessness during sex needs urgent medical attention.
A GP is the usual first stop and can refer on to a gynaecologist, urologist, menopause specialist, sexual health physician or pelvic-health physiotherapist. A sex therapist or psychologist with sexual-health training is a good parallel step when worry, grief, shame or relationship strain are part of the picture. Be wary of anyone who promises a cure or asks you to stop a prescribed medicine.